|
Iranian registry of clinical trials identifier
|
CTO_0000013 |
|
|
The Netherlands national trial register
|
CTO_0000012 |
|
|
JAPIC clinical trials registry
|
CTO_0000019 |
|
|
The Netherlands national trial register identifier
|
CTO_0000018 |
|
|
Pan African clinical trial registry
|
CTO_0000017 |
|
|
clinical trial outcome measurement
|
CTO_0000016 |
|
|
assay
|
OBI_0000070 |
|
|
Health Services Research
|
NCIT_C15245 |
|
|
Study Primary Purpose
|
NCIT_C147141 |
|
|
cellular organisms
|
NCBITaxon_131567 |
|
|
root
|
NCBITaxon_1 |
|
|
phase 1 vaccine trial
|
VO_0000427 |
|
|
vaccine clinical trial
|
VO_0000596 |
|
|
legal person role
|
OMRSE_00000038 |
|
|
healthy volunteer criterion
|
CTO_0000033 |
|
|
inclusion criterion
|
OBI_0500027 |
|
|
Primary Outcome Measure
|
NCIT_C98772 |
|
|
study result
|
CTO_0000032 |
|
|
data item
|
IAO_0000027 |
|
|
phase 3 vaccine trial
|
VO_0000429 |
|
